BD (NYSE:BDX) announced today that it appointed Dr. Joseph M. Smith as its new senior vice president and chief scientific officer.

Franklin Lakes, New Jersey-based BD said in a news release that Smith’s position with the company has been made effective today.

Smith will be responsible for external innovation and BD’s technology roadmap for smart connected care, the transition to new care settings and chronic disease. He will work with external technology partnerships and oversee the development of new innovation models, BD said.

Additionally, Smith will establish and co-chair the BD Scientific Advisory Board (SAB), which will include top external medical key opinion leaders, science and technology experts and experienced innovation leaders. He will report to BD EVP & CTO Elizabeth McCombs.

Smith previously served as president & CEO of Digital Health Corp. He has also served as president for a digital transformation consultancy and has held positions at Johnson & Johnson, Boston Scientific and the West Health Institute.

“Joe is a digital health pioneer who brings more than 30 years of experience to BD, with his life’s work focused on the intersection of medicine and technology,” McCombs said in the release. “Digital technologies have transformed the world and our lives, and we see great potential to apply these technologies, helping health care professionals and organizations achieve better outcomes and patient experiences while optimizing care delivery.

“Joe will help BD push the boundaries in digital health technologies that can accelerate smart connected care, enable the transition to new care settings and improve chronic disease.”